Established in 1994, Meridian Medical Technologies is a vertically integrated branded pharmaceutical company. It develops, manufactures and markets therapies and technologies in the therapeutic areas of cardiovascular, metabolism, neuroscience and acute care. Its manufacturing facilities produce a wide variety of dosage forms, including tablets, capsules, liquids, suspensions, solutions, suppositories, creams, ointments, and injectable and drug products. The company provides Altace, which is an angiotensin-converting enzyme inhibitor. It offers Thrombin-JMI, which aids in controlling bleeding during surgeries. The company also provides Avinza, which is a daily morphine treatment for chronic pain. Its product, Sonata, is a non-benzodiazepine treatment for insomnia. In addition, it offers Levoxyl for the treatment of thyroid disorders. Its products also include Skelaxin, Synercid and auto-injector solutions. Headquartered in Bristol, Tenn., it operates manufacturing facilities in Rochester, Mich.; St. Louis; St. Petersburg, Fla.; and Middletown, Wis.